Press Release
Abies Ventures, Inc.
April 13, 2021

Abies Ventures announces its investment inQuantum Simulation Technologies, Inc.
Abies Ventures, Inc. (Head Office: Tokyo, Japan; Managing Partner: Fuyuki Yamaguchi;
hereafter, “Abies Ventures”) is pleased to announce that Abies Ventures Fund I, L.P. hasinvested in Quantum Simulation Technologies, Inc. (Head Office: Cambridge, Massachusetts,USA; CEO: Toru Shiozaki; hereinafter, "QSimulate"), a company that develops a platform
which enables material property simulation based on quantum mechanics at high throughputs,for its Series Seed round.

Abies Ventures is a Japan-based venture capital firm that aims to discover startups that contribute to
the further development of humanity and the creation of a sustainable society through the use ofadvanced science and engineering technology (deep tech), and to develop them into global companies.
Its focus areas include functional materials, which Japan is globally competitive, and advanced
computing technologies that accelerate data science.
As the complexity of new materials development and drug discovery accelerates, materials informatics(MI), a method that makes full use of computer simulations and AI, is attracting attention to increase
the speed of development. Abies Ventures believes that MI has the potential to accelerate thedevelopment of breakthrough new materials and drugs, as well as change the landscape of thechemical and pharmaceutical industries. In MI, it is becoming increasingly important to accumulate
large amounts of highly accurate data for AI-based selection of new material candidates. However,since accurate simulations based on quantum mechanics (QM) require enormous computational
resources and time, it is not easy to accumulate large amounts of highly accurate data. In addition, it
has been practically impossible to apply QM-based simulations to the development ofpharmaceuticals, which have larger molecular weights than chemical materials.
“QSimulate-MI”, QSimulate's innovative cloud-based platform, developed by QSimulate based on
years of research by Toru Shiozaki, co-founder and CEO of QSimulate, a quantum chemistryresearcher, who earned doctor of engineering from the University of Tokyo and was an associateprofessor at Northwestern University in the U.S., has already been adopted by chemical and material
manufacturers in Japan and the U.S. QSimulate-MI enables automatic QM-based calculations ofmaterial properties for thousands of molecules per day at up to 1,000 times faster speed thanconventional tools, helping to accelerate the new material development for user companies. In
collaboration with a major pharmaceutical manufacturer, QSimulate has also developed a method forscoring the interactions between proteins and drug molecules using QM-based calculations, paving theway for the use of QM simulations in drug discovery. The effectiveness of QSimulate's simulations
has also been confirmed in the development of new drugs for COVID-19. In recognition of theseachievements, the National Institutes of Health (NIH) has awarded QSimulate a grant for innovationof the drug discovery processes using QM simulations. In addition, QSimulate has already developed
simulation tools for quantum computers, and has been selected as a partner for quantum computer
cloud platforms of Google and Amazon.
QSimulate plans to accelerate product and business development by this funding, and considers Japan
to be one of its key markets. Abies Ventures invested in QSimulate because Abies Ventures believes
that QSimulate will open up the next generation of MI and contribute to increasing the developmentcompetitiveness of Japanese chemical, material and pharmaceutical manufacturers.

■ About Abies Ventures
Business: Venture capital to support deep tech startup companies
Headquarters: Minato City, Tokyo, Japan
Representative: Fuyuki Yamaguchi, Managing Partner
URL: https://abies.vc/en■ About QSimulate
Business: Development and sales of next generation quantum mechanics based simulation platform
Headquarters: Cambridge, Massachusetts, USA
Representative: Toru Shiozaki, co-Founder and CEO
URL: https://qsimulate.com/

Please direct all official enquiries regarding this press release to:
Fuyuki Yamaguchi, Abies Ventures, Inc.
Landwork Aoyama Building 2nd Floor, 2-7-26 Kita-aoyama, Minato-ku Tokyo 107-0061 Japan
E-mail: info@abies.vc